Sort
48,018 grants matching “immunotherapy”
Unraveling the Impact of Extracellular Vesicle-Loaded FXR1 mRNA on Re-educating Cancer Microenvironment
$494,160Pradeep Chaluvally-Raghavan · Medical College Of Wisconsin · R01 · FY2025 · CA
Extrinsic and intrinsic factors regulating commensal-specific T helper-17 cells
$494,153Bei Liu · Ohio State University · U01 · FY2020 · AI
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas
$494,120Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2022 · CA
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
$494,030Catherine Leimkuhler Grimes · University Of Delaware · R01 · FY2022 · GM
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
$494,030Catherine Leimkuhler Grimes · University Of Delaware · R01 · FY2021 · GM
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$493,987Darell D Bigner · Duke University · P01 · FY2020 · CA
Gasdermin E and pyroptosis in cancer
$493,985Judy Lieberman · Boston Children'S Hospital · R01 · FY2022 · CA
Gasdermin E and pyroptosis in cancer
$493,985Judy Lieberman · Boston Children'S Hospital · R01 · FY2023 · CA
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
$493,954Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
$493,954Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Targeting telomerase for melanoma therapeutics
$493,948Emmanuel Skordalakes · Wistar Institute · R01 · FY2016 · CA
Molecular Mechanisms of Bladder Cancer Immunometabolism
$493,870Liuqing Yang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening
$493,865Rebecca Marie Lynch · George Washington University · R61 · FY2025 · AI
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
$493,861Abraham Ari Hakimi · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Clinical Investigation of Epigenetic Therapy
$493,856John C Byrd · Ohio State University · P01 · FY2009 · CA
UPIT: Unleash the Potential of Intestinal Transplantation
$493,821Alexander Helmut Kurt Kroemer · Georgetown University · R01 · FY2017 · AI
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
$493,786Arjun Raj · University Of Pennsylvania · R01 · FY2023 · CA
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
$493,785Arjun Raj · University Of Pennsylvania · R01 · FY2022 · CA
Origin and Function of Double Negative T cells in Lupus
$493,762Troy D Randall · University Of Alabama At Birmingham · R01 · FY2025 · AI
Analysis of Fel d 1-specific T cells after airway allergen challenge in asthma
$493,744Gail M Gauvreau · Mcmaster University · U19 · FY2014 · AI
Negative regulation of myeloid-derived suppressive cells in cancer
$493,744Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2018 · CA
The Antigen Repertoire of CD4 T cells from Pancreatic Islets
$493,725Maki Nakayama · University Of Colorado Denver · R01 · FY2022 · DK
Targeting tumor-associated macrophages for triple-negative breast cancer treatment
$493,611Mingye Feng · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
$493,605Weizhou Zhang · University Of Florida · R01 · FY2022 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$493,581Benjamin W. Purow · University Of Virginia · R01 · FY2014 · CA